Cartesian Therapeutics
RNAC
RNAC
65 hedge funds and large institutions have $66.5M invested in Cartesian Therapeutics in 2025 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 19 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 14
Holders
65
Holding in Top 10
–
Calls
$632K
Puts
–
Top Buyers
| 1 | +$735K | |
| 2 | +$469K | |
| 3 | +$440K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$264K |
| 5 |
Renaissance Technologies
New York
|
+$208K |
Top Sellers
| 1 | -$2.01M | |
| 2 | -$1.12M | |
| 3 | -$281K | |
| 4 |
AA
ALPS Advisors
Denver,
Colorado
|
-$256K |
| 5 |
Goldman Sachs
New York
|
-$208K |